{"disease":{"id":"corneal-inflammation","name":"corneal inflammation"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02128113","title":"RTA 408 Ophthalmic Suspension for the Prevention of Corneal Endothelial Cell Loss Following Cataract Surgery - GUARD","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":307,"lead_sponsor_name":"Biogen","has_results":true},{"nct_id":"NCT05626478","title":"Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Cataract Surgery","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Nicole Fram M.D.","has_results":false},{"nct_id":"NCT04521140","title":"Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Corneal Transplant Surgery","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"Nicole Fram M.D.","has_results":false},{"nct_id":"NCT05667337","title":"Open-label Prospective Clinical Trial Evaluating the Safety and Efficacy of Biosynthetic CLP-PEG-MPC Corneal Implants in Patients Undergoing High-risk Deep Anterior Lamellar Keratoplasty.","phase":"NA","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Centre hospitalier de l'Université de Montréal (CHUM)","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}